Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127135) titled 'Identification of the Origin Cell of Pancreatic Neuroendocrine Neoplasms Based on the "Chromosome Amplification" Feature' on June 25.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Peking Union Medical College Hospital
Condition:
Pancreatic Neuroendocrine Tumors
Intervention:
Chromosomally amplified PanNETs.:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-01
Target Sample Size: Chromosomally amplified PanNETs.:30;Chromosomally neutral PanNETs.:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showp...